Drug Profile
Progesterone intranasal - Mattern
Alternative Names: MetP Progesterone Nasal Gel; MPP 22; ProgestoMatLatest Information Update: 25 Dec 2021
Price :
$50
*
At a glance
- Originator Mattern Pharmaceuticals
- Class Hormonal contraceptives; Hormonal replacements; Infertility therapies; Pregnenediones; Small molecules
- Mechanism of Action Progesterone receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Brain injuries; Premenstrual syndrome
Most Recent Events
- 19 Nov 2008 Phase-I clinical trials in Brain injuries (as a neuroprotectant) in Switzerland (Intranasal)
- 19 Nov 2008 Phase-I clinical trials in Premenstrual syndrome in Switzerland (Intranasal)